Using bupivacaine to reduce pain after ureteroscopy for kidney stones
Official title: Double-Blind Randomized Placebo Controlled Trial of Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain
Run by University of Chicago · NCT06635889 · Data updated 2026-11-12
This study tests if using bupivacaine in the bladder after kidney stone surgery can help reduce pain and improve comfort for patients.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 116 (estimated) |
| Sponsor | University of Chicago Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | March 26, 2025 |
| Main results expected | October 2029 |
| Study ends | October 2029 |
| Registry record updated | October 13, 2026 |
| Trial ID | NCT06635889 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older diagnosed with nephrolithiasis who are scheduled for ureteroscopy.
✕Probably not a fit
Patients with a history of allergy to bupivacaine or those with certain medical conditions such as chronic pain syndromes may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of instilling bupivacaine in the bladder after ureteroscopy, a procedure for treating kidney stones. It is a randomized trial comparing the effects of bupivacaine against a placebo (normal saline) on post-operative pain and urinary symptoms. The hypothesis is that bupivacaine will lead to reduced pain and improved quality of life in patients following the procedure. Participants will be monitored for their pain levels and urinary symptoms in the early post-operative period.
Why it matters
Potential benefit: If successful, this approach could significantly reduce post-operative pain and improve recovery for patients undergoing ureteroscopy.
How similar studies have gone: While the use of bupivacaine in other urologic procedures is common, this specific application following ureteroscopy has not been rigorously tested before, making it a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study. * Male or female, aged ≥ 18 years old. * Diagnosis of nephrolithiasis planned for flexible or semi-rigid ureteroscopy in the treatment of stone disease with ureteral stenting. Exclusion Criteria: * Foley catheterization * History of allergy to bupivacaine * Antegrade ureteroscopy * Transplant or ectopic kidney * Ureteral or bladder reconstruction * Pregnancy (which is a contraindication to elective ureteroscopy) * Dialysis * Surgical complication (significant bleeding, ureteral perforation, significant urothelial damage) * Suspicion of untreated urinary tract infection * History of pelvic radiation * Neurologic disease with a diagnosis of neurogenic bladder dysfunction * History of chronic pain (fibromyalgia, interstitial cystitis, opioid abuse)
Where it's running
-
The University of Chicago Medical Center
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Luke Reynolds, MD — University of Chicago
- Study coordinator: Luke Reynolds, MD
- Email: lukereynolds@bsd.uchicago.edu
- Phone: 7137926105
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Suction vs Conventional Ureteral Access Sheaths in Kidney Stone Surgery
This study tests whether using a suction ureteral access sheath during RIRS helps adults clear stones more often and potentially reduces operative time and infections compared with a conventional sheath.
-
Observation vs Upfront Surgery for Asymptomatic Kidney Stones in Children and Adults
This trial tests whether watching asymptomatic kidney stones or performing upfront surgery is better for reducing life disruption in patients aged 6 and older.
-
Tract Closure with Hemostatic Agent in PCNL
This trial tests whether applying a hemostatic agent during tract closure in PCNL helps reduce blood loss compared with balloon tamponade alone.
-
Suction to collapse the kidney's collecting system after RIRS (retrograde intrarenal surgery)
This trial will test whether actively suctioning the kidney's collecting system at the end of RIRS reduces early postoperative pain and infections for adults having kidney stone removal.
-
Early versus delayed shock wave treatment for leftover kidney stones after percutaneous nephrolithotomy
This trial tests whether doing extracorporeal shock wave lithotripsy (ESWL) early or waiting longer after PCNL helps clear leftover kidney stone fragments ≤15 mm with fewer complications.
-
Compare two suction ureteroscope devices for kidney stones (FANS vs CVAC)
This study tests whether two new suction-enabled ureteroscopes (FANS and CVAC) lead to better stone clearance for adults with small to medium kidney stones compared to each other.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.